QVANTEQ
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
QVANTEQ
Social Links:
Industry:
Biotechnology Developer Platform Medical
Founded:
2009-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.qvanteq.com
Total Employee:
1+
Status:
Active
Contact:
41 44 500 98 90
Email Addresses:
[email protected]
Total Funding:
4.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Google Apps For Business
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Verve Ventures
Verve Ventures investment in Seed Round - Qvanteq
Venture Kick
Venture Kick investment in Grant - Qvanteq
Official Site Inspections
http://www.qvanteq.com
- Host name: sl262.web.hostpoint.ch
- IP address: 217.26.54.108
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
